Doxorubicin Unknown Status Phase 4 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00531973A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging